MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Utah Medical Products DPO Ratio 2011-2026 | UTMD
Annual DPO Ratio Utah Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8 | 16 | 18 | 18 | 15.6 | 20.7 | 23 | 22.7 | 22.7 | 21.2 | 14.8 | 20.8 | 17.4 | 22.5 | 21.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23 | 14.8 | 19.5 |
Quarterly DPO Ratio Utah Medical Products
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 16.3 | 17.3 | 17.6 | - | 19.9 | 9.18 | 7.67 | - | 16.4 | 21 | 21.9 | - | 20.2 | 19.6 | 21.1 | - | 22.4 | 19.2 | 18.5 | - | 18.1 | 18.7 | 21.2 | - | 19.6 | 23.1 | 23.9 | - | 21.7 | 22.4 | 22 | - | 23.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 26 | 7.67 | 19.6 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
72.6 | $ 59.8 | -0.96 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
7.87 | $ 115.3 | 1.0 % | $ 3.69 B | USA |
 |
ICU Medical
ICUI
|
39.2 | $ 119.07 | -3.19 % | $ 2.93 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
23.9 | $ 422.83 | -1.22 % | $ 151 B | USA |
 |
Repro Med Systems
KRMD
|
46.1 | $ 3.96 | -0.63 % | $ 183 M | USA |
 |
Alcon
ALC
|
63.6 | $ 63.71 | -0.48 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
13.9 | $ 97.24 | -2.27 % | $ 2.2 B | USA |
 |
Masimo Corporation
MASI
|
84.4 | $ 178.36 | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
91.4 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
54.2 | $ 23.53 | -1.34 % | $ 3.95 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
195 | $ 6.0 | -6.69 % | $ 50.9 K | USA |
 |
Haemonetics Corporation
HAE
|
41.9 | $ 57.22 | 0.18 % | $ 2.88 B | USA |
 |
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
67.2 | $ 142.59 | 0.31 % | $ 6.91 B | USA |
 |
STAAR Surgical Company
STAA
|
37 | $ 32.51 | 1.56 % | $ 1.61 B | USA |
 |
STERIS plc
STE
|
31.8 | $ 212.38 | -1.67 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
47.7 | $ 129.68 | -0.46 % | $ 5.79 B | USA |
 |
InfuSystem Holdings
INFU
|
59.7 | $ 8.68 | 0.52 % | $ 179 M | USA |
 |
Microbot Medical
MBOT
|
34.9 | $ 1.89 | 1.89 % | $ 86.5 M |  Israel |
 |
Milestone Scientific
MLSS
|
66.3 | $ 0.33 | -3.06 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
30.3 | $ 61.52 | -1.66 % | $ 3.64 B | USA |
 |
West Pharmaceutical Services
WST
|
45.7 | $ 304.2 | 1.33 % | $ 22 B | USA |
 |
Pulse Biosciences
PLSE
|
1.51 K | $ 24.37 | -10.07 % | $ 1.64 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
53.7 | $ 9.96 | -4.37 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
46 | $ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
Pro-Dex
PDEX
|
35.4 | $ 60.46 | 3.09 % | $ 199 M | USA |
 |
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
25.9 | $ 20.35 | -3.37 % | $ 972 M | USA |
 |
Stereotaxis
STXS
|
124 | $ 1.89 | -3.08 % | $ 172 M | USA |
 |
Baxter International
BAX
|
45.6 | $ 17.29 | -2.76 % | $ 8.87 B | USA |
 |
ResMed
RMD
|
34.9 | $ 202.34 | -0.06 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
68.7 | $ 27.89 | -0.92 % | $ 1.33 B | USA |
 |
Harvard Bioscience
HBIO
|
42 | $ 5.27 | -4.53 % | $ 234 M | USA |
 |
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
96.2 | $ 10.87 | -1.45 % | $ 444 M | USA |
 |
Becton, Dickinson and Company
BDX
|
59.3 | $ 142.87 | -1.11 % | $ 41.1 B | USA |
 |
Nephros
NEPH
|
39.8 | $ 3.18 | -4.79 % | $ 33.7 M | USA |
 |
OraSure Technologies
OSUR
|
40.1 | $ 3.07 | 3.9 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
32.2 | $ 104.92 | 1.49 % | $ 5.9 M | USA |